Deficiency of bone marrow β3-integrin enhances non-functional neovascularization

Journal of Pathology

Volumn 220, Issue 4, 2010, Pages 435-445

  Watson, Alan R ^a,b   Pitchford, Simon C ^c   Reynolds, Louise E ^b   Direkze, Natalie ^a   Brittan, Mairi ^d   Alison, Malcolm R ^d   Rankin, Sara ^c   Wright, Nicholas A ^a   Hodivala Dilke, Kairbaan M ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

3 integrin; Adhesion; Adoptive transfer; Angiogenesis; Bone marrow; Tumour

Indexed keywords

BETA3 INTEGRIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA3 INTEGRIN DEFICIENCY; BONE MARROW TRANSPLANTATION; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEMATOPOIETIC STEM CELL; HISTOPATHOLOGY; LEUKOCYTE; LEWIS CARCINOMA; LUNG METASTASIS; MELANOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TUMOR GROWTH; WILD TYPE;

ANIMALS; BONE MARROW; BONE MARROW TRANSPLANTATION; CARCINOMA, LEWIS LUNG; CELL MOVEMENT; ENDOTHELIAL CELLS; FEMALE; HEMATOPOIETIC STEM CELLS; INTEGRIN BETA3; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 76749103879     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2660     Document Type: Article

References (30)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-1028.
3. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999;103:159-165.
4. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular per-meability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-1039.
5. Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A. The history of the angiogenic switch concept. Leukemia 2007;21:44-52.
6. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-4387.
7. Spring H, Schuler T, Arnold B, Hammerling GJ, Ganss R. Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 2005;102:18111-18116.
8. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006;313:1785-1787.
9. Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001;193:1005-1014.
10. Okamoto R, Ueno M, Yamada Y, Takahashi N, Sano H, Suda T, et al. Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood 2005;105:2757-2763.
11. Chen H, Campbell RA, Chang Y, Li M, Wang CS, Li J, et al. Pleiotrophin produced by multiple myeloma induces trans-differentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis. Blood 2009;113:1992-2002.
12. Sharifi BG, Zeng Z, Wang L, Song L, Chen H, Qin M, et al. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol 2006;26:1273- 1280.
13. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
14. Asahara T, Takahashi T,Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964- 3972.
15. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008;319:195-198.
16. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci USA 2008;105:6620-6625.
17. Wickersheim A, Kerber M, de Miguel LS, Plate KH, Machein MR. Endothelial progenitor cells do not contribute to tumor endothelium in primary and metastatic tumors. Int J Cancer 2009;125:1771-1777.
18. Avraamides CJ, Garmy-Susini B, Varner JA. Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 2008;8:604-617.
19. Jin H, Su J, Garmy-Susini B, Kleeman J, Varner J. Integrin α 4β1 promotes monocyte trafficking and angiogenesis in tumors. Cancer Res 2006;66:2146-2152.
20. Smadja DM, Bieche I, Helley D, Laurendeau I, Simonin G, Muller L, et al. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin α(6). J Cell Mol Med 2007;11:1149-1161.
21. Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, et al. Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins. Nat Med 2002;8:27-34.
22. Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, et al. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in β3-integrin-deficient mice. Cancer Res 2004;64:8643-8650.
23. Taverna D, Moher H, Crowley D, Borsig L, Varki A, Hynes RO. Increased primary tumor growth in mice null for β3- or β3/β5-integrins or selectins. Proc Natl Acad Sci USA 2004;101:763-768.
24. Mahabeleshwar GH, Feng W, Phillips DR, Byzova TV. Integrin signaling is critical for pathological angiogenesis. J Exp Med 2006;203:2495- 2507.
25. Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, Phillips DR. Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function. Nature 1999;401:808-811.
26. Feng W, McCabe NP, Mahabeleshwar GH, Somanath PR, Phillips DR, Byzova TV. The angiogenic response is dictated by β3 integrin on bone marrow-derived cells. J Cell Biol 2008;183:1145-1157.
27. Wang ZZ, Au P, Chen T, Shao Y, Daheron LM, Bai H, et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 2007;25:317-318.
28. Brittan M, Chance V, Elia G, Poulsom R, Alison MR, MacDonald TT, et al. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 2005;128:1984-1995.
29. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 2009;4:62-72.
30. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007;109:1801-1809.